P
Peter B. van den Boezem
Researcher at Radboud University Nijmegen
Publications - 32
Citations - 1311
Peter B. van den Boezem is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 12, co-authored 25 publications receiving 805 citations. Previous affiliations of Peter B. van den Boezem include Radboud University Nijmegen Medical Centre & Leiden University Medical Center.
Papers
More filters
Journal ArticleDOI
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2) : a multicentre, patient-blinded, randomised controlled phase 2/3 trial
Jony van Hilst,Thijs de Rooij,Koop Bosscha,David J. Brinkman,Susan van Dieren,Marcel G. W. Dijkgraaf,Michael F. Gerhards,Ignace H. J. T. de Hingh,Tom M. Karsten,D.J. Lips,D.J. Lips,Misha D. P. Luyer,Olivier R. Busch,Sebastiaan Festen,Marc G. Besselink,Hendrik A. Marsman,Thomas M. van Gulik,Dennis A. Wicherts,Wietse J. Eshuis,Luna A Stibbe,Els Jm Nieveen van Dijkum,Janine E Van Hooft,Paul Fockens,Hanneke W. M. van Laarhoven,Johanna W. Wilmink,Marcel J Van de Vijver,Maarten F. Bijlsma,Joanne Verheij,C. Yung Nio,Krijn P. van Lienden,Geertjan van Tienhoven,Annuska Schoorlemmer,Geert-Jan Creemers,Casper H.J. van Eijck,Bas Groot Koerkamp,Marco J. Bruno,Ferry A.L.M. Eskens,Joost J. Nuyttens,Chulja Pek,George P. van der Schelling,Tom C.J. Seerden,Gijs A. Patijn,Vincent B. Nieuwenhuijs,Jan Willem B. de Groot,Bert A. Bonsing,Alexander L. Vahrmeijer,R.-J. Swijnenburg,J. Sven D. Mieog,Erwin van der Harst,Matthijs Den Dulk,Steven W.M. Olde Damink,Cees H. Dejong,Ronald Van Dam,Judith Mpgm De Vos,Mike Sl Liem,Cees J. H. M. van Laarhoven,Harry van Goor,Peter B. van den Boezem,B. Marion van der Kolk,Martijn Wj Stommel,John J. Hermans,Erwin J M van Geenen,Sandra A Radema,Lodewijk A.A. Brosens,Joris J. Scheepers,Daphne Roos,Djamilla Boerma,Wouter W. te Riele,Hjalmar C. van Santvoort,Thomas L. Bollen,Fanny Wit,I. Quintus Molenaar,Nadia Haj Mohammad,Maarten S. van Leeuwen,Annemarie Roele,Kees P De Jong,Vincent E de Meijer,Joost M. Klaase,Geert Kazemier,Babs M Zonderhuis,Freek Daams,Martijn R. Meijerink,Anouk E J Latenstein,L. Bengt van Rijssen,Carolijn L.M.A. Nota,Emo Van Halsema,Eran van Veldhuisen,Jantien A. Vogel,Kiki Janssen,Lianne Scholten,Lois A. Daamen,Marieke S. Walma,Marin Strijker,Mariska Prins,Maurice J. W. Zwart,Mustafa Suker,Steffi J.E. Rombouts,Timothy H. Mungroop,F. Vissers,Maarten Korrel +99 more
TL;DR: This multicentre, patient-blinded, parallel-group, randomised controlled phase 2/3 trial was performed in four centres in the Netherlands to assess whether laparoscopic pancreatoduodenectomy could reduce time to functional recovery compared with open pancreatic fistula.
Journal ArticleDOI
Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD): A Multicenter Patient-blinded Randomized Controlled Trial.
Thijs de Rooij,Jony van Hilst,Hjalmar C. van Santvoort,Djamila Boerma,Peter B. van den Boezem,Freek Daams,Ronald M. van Dam,Cees H. Dejong,Eino B. van Duyn,Marcel G. W. Dijkgraaf,Casper H.J. van Eijck,Sebastiaan Festen,Michael F. Gerhards,Bas Groot Koerkamp,Ignace H. J. T. de Hingh,Geert Kazemier,Joost M. Klaase,Ruben H J de Kleine,Cornelis J. H. M. van Laarhoven,Misha D. P. Luyer,Gijs A. Patijn,Pascal Steenvoorde,Mustafa Suker,Moh'd Abu Hilal,Olivier R. Busch,Marc G. Besselink +25 more
TL;DR: In patients with left-sided pancreatic tumors confined to the pancreas, MIDP reduces time to functional recovery compared with ODP and was associated with less delayed gastric emptying and better quality of life without increasing costs.
Journal ArticleDOI
Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases - a meta-analysis.
Martinus J. van Amerongen,Sjoerd F. M. Jenniskens,Peter B. van den Boezem,Jurgen J. Fütterer,Jurgen J. Fütterer,Johannes H. W. de Wilt +5 more
TL;DR: RFA showed a significantly lower rate of complications, but also a lower survival and a higher rate of recurrence as compared to surgical resection, and randomized clinical trials are needed to accurately evaluate these treatment modalities.
Journal ArticleDOI
Multicenter Observational Study of Adhesion Formation After Open-and Laparoscopic Surgery for Colorectal Cancer
Martijn W J Stommel,Richard P. G. ten Broek,Chema Strik,Gerrit D. Slooter,Cornelis Verhoef,Dirk J. Grünhagen,Peter van Duijvendijk,Marc H.A. Bemelmans,Marcel den Dulk,C. Sietses,Tjarda N. T. van Heek,Peter B. van den Boezem,Johannes H. W. de Wilt,Harry van Goor +13 more
TL;DR: Laroscopic colorectal cancer resection is associated with a lower incidence, extent, and severity of adhesions to parietal surfaces, and laparoscopy does not reduce the incidence of visceral adhesion.
Journal ArticleDOI
Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases : Multidisciplinary Consensus Document from the COLLISION Trial Group
Sanne Nieuwenhuizen,Robbert S. Puijk,Bente van den Bemd,Luca Aldrighetti,Mark J. Arntz,Peter B. van den Boezem,A. Bruynzeel,Mark C. Burgmans,Francesco De Cobelli,Marielle M.E. Coolsen,Cornelis H. C. Dejong,Sarah Derks,Arjen Diederik,Peter van Duijvendijk,Hasan H. Eker,Anton F. Engelsman,Joris I. Erdmann,Jurgen J. Fütterer,Bart Geboers,Gerie Groot,C.J.A. Haasbeek,Jan Jaap Janssen,Koert P. de Jong,G. Matthijs Kater,Geert Kazemier,Johan W.H. Kruimer,Wouter K. G. Leclercq,Christiaan van der Leij,Eric R. Manusama,Mark A.J. Meier,Bram B. van der Meijs,Marleen C. A. M. Melenhorst,Karin Nielsen,Maarten W Nijkamp,Fons H. Potters,Warner Prevoo,Floris J. Rietema,Alette H. Ruarus,Simeon J. S. Ruiter,Evelien A. C. Schouten,Gian Piero Serafino,Colin Sietses,Rutger-Jan Swijnenburg,Florentine E. F. Timmer,Kathelijn S. Versteeg,Ted Vink,Jan J. J. de Vries,Johannes H. W. de Wilt,B.M. Zonderhuis,Hester J. Scheffer,Petrousjka van den Tol,Martijn R. Meijerink +51 more
TL;DR: An interdisciplinary, consensus-based algorithm with specific resectability and ablatability criteria for the treatment of colorectal liver metastases (CRLM) is created to aid tumor board discussions, improve consistency when designing prospective trials and advance intersociety communications.